|
Effectiveness of Cissus quadrangularis formulation on serological characteristics: Percent difference in means from Week 0 to Week 8 |
||||
| BMI |
Greater than 30 (Obese) |
25 – 29 (Overweight) |
||
|
|
||||
| Treatment |
Placebo (n = 30) |
Formulation/no diet (n = 31) |
Formulation/Diet (n = 31) |
Formulation/no diet (n = 31) |
|
|
||||
| Serological Characteristics* |
||||
| Total Cholesterol (%) |
-3.1 (28.7) |
-27.0 (14.6)a |
-26.0 (13.3)a |
-18.8 (17.0)b |
| LDL Cholesterol (%) |
-10.4 (13.4) |
-18.4 (9.8)c |
-32.4 (15.5)a |
-26.4 (12.8)a |
| HDL Cholesterol (%) |
17.4 (38.8) |
50.5 (50.7)b |
43.0 (39.5)c |
19.6 (37.0) |
| Triglycerides (%) |
-4.5 (25.4) |
-36.8 (17.8)a |
-28.0 (12.2)a |
-15.0 (15.3)c |
| C-Reactive Protein (%) |
0.8 (13.2) |
-20.8 (11.2)a |
-20.8 (10.0)a |
-16.3 (13.2)a |
| Fasting Blood Glucose (%) |
-4.6 (14.8) |
-13.4 (13.6)b |
-16.1 (13.4)a |
-11.4 (11.8)c |
|
* These data are shown as means with standard deviations in parentheses a P = <0.001 versus placebo b P = <0.01 versus placebo c P = <0.05 versus placebo | ||||
Oben et al. Lipids in Health and Disease 2006 5:24 doi:10.1186/1476-511X-5-24 |
||||